The Effect of Aerobic Exercise on Selective Biomarkers of Patients With Cancer
The Effect of Supervised Aerobic Exercise on Adipokine and Myokine Biomarkers in Patients With Cancer During Systemic Chemotherapy
1 other identifier
observational
32
1 country
1
Brief Summary
This study is a single-blinded, prospective, controlled trial aiming to evaluate the effect of supervised aerobic exercise on adipokine and myokine biomarkers in patients with breast or colon cancer during their systemic chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 10, 2025
CompletedFirst Posted
Study publicly available on registry
July 3, 2025
CompletedJuly 3, 2025
June 1, 2025
11 months
June 10, 2025
June 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Irisin
Measuring Serum levels of Irisin via ELISA
Baseline
Irisin
Measuring Serum levels of Irisin via ELISA
From completion of systemic chemotherapy up to one week
Leptin
Measuring Serum levels of Leptin via ELISA
Baseline
Leptin
Measuring Serum levels of Leptin via ELISA
From completion of systemic chemotherapy up to one week
Adiponectin
Measuring Serum levels of Adiponectin via ELISA
Baseline
Adiponectin
Measuring Serum levels of Adiponectin via ELISA
From completion of systemic chemotherapy up to one week
Interleukin-6 (IL-6)
Measuring Serum levels of IL-6 via ELISA
Baseline
Interleukin-6 (IL-6)
Measuring Serum levels of IL-6 via ELISA
From completion of systemic chemotherapy up to one week
Study Arms (2)
Exercise Group
Patients who will be willing to participate in supervised exercise will be grouped in Exercise Group (EG).
Control Group
Patients who are not willing to participate in exercise due to various reasons (time restrictions, other obligations, transport, etc.) will be grouped in the Control Group (CG).
Interventions
The exercise program will be started with 25 Watt (W) for 5 minutes of warm-up. Then it is steadily increased automatically by 5W in 5 minutes apart for 25 minutes for the loading period. The last 5 minutes which will be started by lowering the load to 25 W for cooling will be implemented for cooling down. To prevent acommodation, the warm-up period will be modified by increasing nearly 10% of its previous rate three weeks apart.A submaximal exercise prescription will be followed according to the American College of Sports Medicine guideline by taking into attention 50-70% of Heart Rate Reserve.A submaximal exercise prescription will be followed according to the American College of Sports Medicine guideline by taking into attention 50-70% of Heart Rate Reserve.
Eligibility Criteria
Having been diagnosed with solid type of cancer (specifically breast or colon) and being candidate for undergoing systemic chemotherapy.
You may qualify if:
- Having been diagnosed with solid type of cancer
- Being candidate for systemic chemotherapy
- Being volunteer to participate in an exercise program
- Aged between 18-70 years old
You may not qualify if:
- Having 2 or above grades according to the Eastern Cooperative Oncology Group (ECOG) performance status
- Having mental and/or cognitive deficits
- Ongoing medical and/or surgical (if any) complications
- Having neurological/orthopedical and/or severe respiratory dysfunctions
- Having any condition which corresponds to the contraindication of exercise (i.e. advanced stages, distant metastasis, infection)
- Having unstable vital parameters or having regularly used pharmacological interventions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bakircay University Çiğli State and Training Hospital, Department of Medical Oncology
Izmir, Çiğli, 35620, Turkey (Türkiye)
Related Publications (7)
Brownson-Smith R, Orange ST, Cresti N, Hunt K, Saxton J, Temesi J. Effect of exercise before and/or during taxane-containing chemotherapy treatment on chemotherapy-induced peripheral neuropathy symptoms in women with breast cancer: systematic review and meta-analysis. J Cancer Surviv. 2025 Feb;19(1):78-96. doi: 10.1007/s11764-023-01450-w. Epub 2023 Aug 24.
PMID: 37615928BACKGROUNDKim JS, Galvao DA, Newton RU, Gray E, Taaffe DR. Exercise-induced myokines and their effect on prostate cancer. Nat Rev Urol. 2021 Sep;18(9):519-542. doi: 10.1038/s41585-021-00476-y. Epub 2021 Jun 22.
PMID: 34158658BACKGROUNDTsiani E, Tsakiridis N, Kouvelioti R, Jaglanian A, Klentrou P. Current Evidence of the Role of the Myokine Irisin in Cancer. Cancers (Basel). 2021 May 27;13(11):2628. doi: 10.3390/cancers13112628.
PMID: 34071869BACKGROUNDDieli-Conwright CM, Courneya KS, Demark-Wahnefried W, Sami N, Lee K, Buchanan TA, Spicer DV, Tripathy D, Bernstein L, Mortimer JE. Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial. J Clin Oncol. 2018 Mar 20;36(9):875-883. doi: 10.1200/JCO.2017.75.7526. Epub 2018 Jan 22.
PMID: 29356607BACKGROUNDMeneses-Echavez JF, Correa-Bautista JE, Gonzalez-Jimenez E, Schmidt Rio-Valle J, Elkins MR, Lobelo F, Ramirez-Velez R. The Effect of Exercise Training on Mediators of Inflammation in Breast Cancer Survivors: A Systematic Review with Meta-analysis. Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1009-17. doi: 10.1158/1055-9965.EPI-15-1061. Epub 2016 Apr 12.
PMID: 27197276BACKGROUNDTjoe JA, Piacentine LB, Papanek PE, Raff H, Richards J, Harkins AL, Yin J, Ng AV. Team triathlon effects on physiological, psychological, and immunological measures in women breast cancer survivors. Support Care Cancer. 2020 Dec;28(12):6095-6104. doi: 10.1007/s00520-020-05457-2. Epub 2020 Apr 20.
PMID: 32314053BACKGROUNDTugral A, Aribas Z, Kaya Ucar G, Arslan FD, Bakar Y, Karakoyun I, Akyol M. The effect of supervised aerobic exercise on adipokine and myokine biomarkers in patients with cancer during systemic chemotherapy: a single-blinded prospective controlled trial. Support Care Cancer. 2025 Aug 2;33(8):741. doi: 10.1007/s00520-025-09788-w.
PMID: 40751845DERIVED
Biospecimen
For both EG and CG, two blood samplings were performed for each patient. 5 cc venous blood was collected from all the participants and centrifuged at 1500 g for 10 minutes. Separated serum was stored at -20 °C until analysis. Serum leptin, IL-6, irisin, and adiponectin concentrations were measured by using enzyme-linked immunosorbent assay (ELISA) method.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alper Tuğral, PhD
Izmir Bakircay University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Project Coordinator
Study Record Dates
First Submitted
June 10, 2025
First Posted
July 3, 2025
Study Start
September 15, 2022
Primary Completion
August 15, 2023
Study Completion
December 1, 2023
Last Updated
July 3, 2025
Record last verified: 2025-06